Skip to main content
PR

PreciseDx

New York, United States
Last funding
$3.7M
Venture - Series UnknownOct 2026

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.

Backed byLabCorpAgilent TechnologiesQuest DiagnosticsIBM VenturesMerck Global Health Innovation Fund

About PreciseDx

How much funding has PreciseDx raised?

PreciseDx has raised $3.7M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2026.

Who are PreciseDx's investors?

PreciseDx's investors include LabCorp, Agilent Technologies, Quest Diagnostics, IBM Ventures, Merck Global Health Innovation Fund.

Where is PreciseDx headquartered?

PreciseDx is headquartered in New York, United States.

What does PreciseDx do?

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.

What stage is PreciseDx at?

PreciseDx is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"PreciseDx — Funding & Investors." VCBacked, October 7, 2026, https://www.vcbacked.co/company/precisedx. Accessed November 22, 2026.
APA
VCBacked. (2026). PreciseDx — Funding & Investors. Retrieved November 22, 2026, from https://www.vcbacked.co/company/precisedx
Wikipedia (cite web)
{{cite web |title=PreciseDx — Funding & Investors |url=https://www.vcbacked.co/company/precisedx |website=VCBacked |access-date=November 22, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at PreciseDx? Request a listing update

Founder contacts
m***@precisedx.ai
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →